{"cik":1637715,"entityName":"Reneo Pharmaceuticals, Inc.","facts":{"dei":{"EntityCommonStockSharesOutstanding":{"label":"Entity Common Stock, Shares Outstanding","description":"Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.","units":{"shares":[{"end":"2021-05-14","val":24286253,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1I"}]}}},"us-gaap":{"AccountsPayableCurrent":{"label":"Accounts Payable, Current","description":"Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2020-12-31","val":908000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q4I"},{"end":"2021-03-31","val":556000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1I"}]}},"AccretionAmortizationOfDiscountsAndPremiumsInvestments":{"label":"Accretion (Amortization) of Discounts and Premiums, Investments","description":"The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":15000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q1"}]}},"AccruedLiabilitiesCurrent":{"label":"Accrued Liabilities, Current","description":"Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2020-12-31","val":3672000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q4I"},{"end":"2021-03-31","val":3374000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1I"}]}},"AccruedSalariesCurrent":{"label":"Accrued Salaries, Current","description":"Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2020-12-31","val":888000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q4I"},{"end":"2021-03-31","val":514000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1I"}]}},"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment":{"label":"Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment","description":"Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.","units":{"USD":[{"end":"2020-12-31","val":83000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q4I"},{"end":"2021-03-31","val":93000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1I"}]}},"AdditionalPaidInCapital":{"label":"Additional Paid in Capital","description":"Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.","units":{"USD":[{"end":"2020-12-31","val":2843000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q4I"},{"end":"2021-03-31","val":3453000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1I"}]}},"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue":{"label":"APIC, Share-based Payment Arrangement, Increase for Cost Recognition","description":"Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":92000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":471000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1"}]}},"AllocatedShareBasedCompensationExpense":{"label":"Share-based Payment Arrangement, Expense","description":"Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":92000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":471000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1"}]}},"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount":{"label":"Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount","description":"Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.","units":{"shares":[{"start":"2020-01-01","end":"2020-03-31","val":6407087,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":19021269,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1"}]}},"Assets":{"label":"Assets","description":"Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.","units":{"USD":[{"end":"2020-12-31","val":55221000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q4I"},{"end":"2021-03-31","val":95321000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1I"}]}},"AssetsCurrent":{"label":"Assets, Current","description":"Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.","units":{"USD":[{"end":"2020-12-31","val":55025000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q4I"},{"end":"2021-03-31","val":93560000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1I"}]}},"AssetsFairValueDisclosure":{"label":"Assets, Fair Value Disclosure","description":"Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.","units":{"USD":[{"end":"2020-12-31","val":49632000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q4I"},{"end":"2021-03-31","val":89563000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1I"}]}},"CapitalExpendituresIncurredButNotYetPaid":{"label":"Capital Expenditures Incurred but Not yet Paid","description":"Future cash outflow to pay for purchases of fixed assets that have occurred.","units":{"USD":[{"start":"2021-01-01","end":"2021-03-31","val":2000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1"}]}},"CashAndCashEquivalentsAtCarryingValue":{"label":"Cash and Cash Equivalents, at Carrying Value","description":"Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.","units":{"USD":[{"end":"2020-12-31","val":53613000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q4I"},{"end":"2021-03-31","val":91221000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1I"}]}},"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents":{"label":"Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents","description":"Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.","units":{"USD":[{"end":"2019-12-31","val":17501000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2019Q4I"},{"end":"2020-03-31","val":18279000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q1I"},{"end":"2020-12-31","val":53613000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q4I"},{"end":"2021-03-31","val":91221000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1I"}]}},"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect":{"label":"Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect","description":"Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":778000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":37608000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1"}]}},"CommonStockCapitalSharesReservedForFutureIssuance":{"label":"Common Stock, Capital Shares Reserved for Future Issuance","description":"Aggregate number of common shares reserved for future issuance.","units":{"shares":[{"end":"2021-03-31","val":19138871,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1I"}]}},"CommonStockParOrStatedValuePerShare":{"label":"Common Stock, Par or Stated Value Per Share","description":"Face amount or stated value per share of common stock.","units":{"USD/shares":[{"end":"2020-12-31","val":0.0001,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q4I"},{"end":"2021-03-31","val":0.0001,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1I"}]}},"CommonStockSharesAuthorized":{"label":"Common Stock, Shares Authorized","description":"The maximum number of common shares permitted to be issued by an entity's charter and bylaws.","units":{"shares":[{"end":"2020-12-31","val":105000000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q4I"},{"end":"2021-03-31","val":105000000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1I"}]}},"CommonStockSharesIssued":{"label":"Common Stock, Shares, Issued","description":"Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.","units":{"shares":[{"end":"2020-12-31","val":2053070,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q4I"},{"end":"2021-03-31","val":2148193,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1I"}]}},"CommonStockSharesOutstanding":{"label":"Common Stock, Shares, Outstanding","description":"Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.","units":{"shares":[{"end":"2020-12-31","val":2053070,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q4I"},{"end":"2021-03-31","val":2123733,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1I"}]}},"ComprehensiveIncomeNetOfTax":{"label":"Comprehensive Income (Loss), Net of Tax, Attributable to Parent","description":"Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":-4425000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-7212000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1"}]}},"DeferredRentCreditNoncurrent":{"label":"Deferred Rent Credit, Noncurrent","description":"For a classified balance sheet, the cumulative difference between the rental income or payments required by a lease agreement and the rental income or expense recognized on a straight-line basis, or other systematic and rational basis more representative of the time pattern in which use or benefit is granted or derived from the leased property, expected to be recognized in income or expense, by the lessor or lessee, respectively, more than one year after the balance sheet date.","units":{"USD":[{"end":"2020-12-31","val":36000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q4I"},{"end":"2021-03-31","val":32000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1I"}]}},"DepreciationDepletionAndAmortization":{"label":"Depreciation, Depletion and Amortization","description":"The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":9000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":10000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1"}]}},"EarningsPerShareBasicAndDiluted":{"label":"Earnings Per Share, Basic and Diluted","description":"The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.","units":{"USD/shares":[{"start":"2020-01-01","end":"2020-03-31","val":-2.2,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-3.48,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1"}]}},"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized":{"label":"Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount","description":"Amount of cost not yet recognized for nonvested award under share-based payment arrangement.","units":{"USD":[{"end":"2021-03-31","val":7200000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1I"}]}},"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3":{"label":"Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3","description":"Amount of transfers of financial instrument classified as a liability into level 3 of the fair value hierarchy.","units":{"USD":[{"start":"2021-01-01","end":"2021-03-31","val":0,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1"}]}},"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3":{"label":"Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3","description":"Amount of transfers of financial instrument classified as a liability out of level 3 of the fair value hierarchy.","units":{"USD":[{"start":"2021-01-01","end":"2021-03-31","val":0,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1"}]}},"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3":{"label":"Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3","description":"Amount of transfer of financial instrument classified as an asset into level 3 of the fair value hierarchy.","units":{"USD":[{"start":"2021-01-01","end":"2021-03-31","val":0,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1"}]}},"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3":{"label":"Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3","description":"Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy.","units":{"USD":[{"start":"2021-01-01","end":"2021-03-31","val":0,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1"}]}},"GeneralAndAdministrativeExpense":{"label":"General and Administrative Expense","description":"The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":924000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":1742000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1"}]}},"ImpairmentOfInvestments":{"label":"Other than Temporary Impairment Losses, Investments","description":"The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":0,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":0,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1"}]}},"ImpairmentOfLongLivedAssetsHeldForUse":{"label":"Impairment of Long-Lived Assets Held-for-use","description":"The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).","units":{"USD":[{"start":"2020-01-01","end":"2021-03-31","val":0,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20"}]}},"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities":{"label":"Increase (Decrease) in Accounts Payable and Accrued Liabilities","description":"The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":36000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-927000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1"}]}},"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets":{"label":"Increase (Decrease) in Prepaid Expense and Other Assets","description":"Amount of increase (decrease) in prepaid expenses, and assets classified as other.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":137000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":929000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1"}]}},"Liabilities":{"label":"Liabilities","description":"Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.","units":{"USD":[{"end":"2020-12-31","val":4616000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q4I"},{"end":"2021-03-31","val":3962000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1I"}]}},"LiabilitiesAndStockholdersEquity":{"label":"Liabilities and Equity","description":"Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.","units":{"USD":[{"end":"2020-12-31","val":55221000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q4I"},{"end":"2021-03-31","val":95321000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1I"}]}},"LiabilitiesCurrent":{"label":"Liabilities, Current","description":"Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":4580000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q4I"},{"end":"2021-03-31","val":3930000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1I"}]}},"NetCashProvidedByUsedInFinancingActivities":{"label":"Net Cash Provided by (Used in) Financing Activities","description":"Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":26000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":46222000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1"}]}},"NetCashProvidedByUsedInInvestingActivities":{"label":"Net Cash Provided by (Used in) Investing Activities","description":"Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":5199000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-25000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1"}]}},"NetCashProvidedByUsedInOperatingActivities":{"label":"Net Cash Provided by (Used in) Operating Activities","description":"Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":-4447000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-8589000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1"}]}},"NetIncomeLoss":{"label":"Net Income (Loss) Attributable to Parent","description":"The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":-4431000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-7212000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1"}]}},"NumberOfOperatingSegments":{"label":"Number of Operating Segments","description":"Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.","units":{"segment":[{"start":"2021-01-01","end":"2021-03-31","val":1,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1"}]}},"OperatingExpenses":{"label":"Operating Expenses","description":"Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":4502000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":7214000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1"}]}},"OperatingIncomeLoss":{"label":"Operating Income (Loss)","description":"The net result for the period of deducting operating expenses from operating revenues.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":-4502000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-7214000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1"}]}},"OperatingLeaseExpense":{"label":"Operating Lease, Expense","description":"Amount of operating lease expense. Excludes sublease income.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":46000000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":46000000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1"}]}},"OtherAccruedLiabilitiesCurrent":{"label":"Other Accrued Liabilities, Current","description":"Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":322000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q4I"},{"end":"2021-03-31","val":704000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1I"}]}},"OtherAssetsNoncurrent":{"label":"Other Assets, Noncurrent","description":"Amount of noncurrent assets classified as other.","units":{"USD":[{"end":"2020-12-31","val":127000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q4I"},{"end":"2021-03-31","val":1680000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1I"}]}},"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax":{"label":"OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax","description":"Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":6000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q1"}]}},"OtherNonoperatingIncome":{"label":"Other Nonoperating Income","description":"Amount of income related to nonoperating activities, classified as other.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":71000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":2000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1"}]}},"PaymentsOfStockIssuanceCosts":{"label":"Payments of Stock Issuance Costs","description":"The cash outflow for cost incurred directly with the issuance of an equity security.","units":{"USD":[{"start":"2021-01-01","end":"2021-03-31","val":1223000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1"}]}},"PaymentsToAcquirePropertyPlantAndEquipment":{"label":"Payments to Acquire Property, Plant, and Equipment","description":"The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":1000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":25000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1"}]}},"PrepaidExpenseAndOtherAssetsCurrent":{"label":"Prepaid Expense and Other Assets, Current","description":"Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":1412000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q4I"},{"end":"2021-03-31","val":2339000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1I"}]}},"ProceedsFromIssuanceOfPrivatePlacement":{"label":"Proceeds from Issuance of Private Placement","description":"The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.","units":{"USD":[{"start":"2021-01-01","end":"2021-03-31","val":146700000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1"}]}},"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities":{"label":"Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale","description":"Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":5200000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q1"}]}},"ProceedsFromStockOptionsExercised":{"label":"Proceeds from Stock Options Exercised","description":"Amount of cash inflow from exercise of option under share-based payment arrangement.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":26000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":187000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1"}]}},"PropertyPlantAndEquipmentGross":{"label":"Property, Plant and Equipment, Gross","description":"Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.","units":{"USD":[{"end":"2020-12-31","val":152000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q4I"},{"end":"2021-03-31","val":174000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1I"}]}},"PropertyPlantAndEquipmentNet":{"label":"Property, Plant and Equipment, Net","description":"Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.","units":{"USD":[{"end":"2020-12-31","val":69000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q4I"},{"end":"2021-03-31","val":81000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1I"}]}},"ResearchAndDevelopmentExpense":{"label":"Research and Development Expense","description":"The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":3578000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":5472000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1"}]}},"RetainedEarningsAccumulatedDeficit":{"label":"Retained Earnings (Accumulated Deficit)","description":"The cumulative amount of the reporting entity's undistributed earnings or deficit.","units":{"USD":[{"end":"2020-12-31","val":-44958000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q4I"},{"end":"2021-03-31","val":-52170000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1I"}]}},"ShareBasedCompensation":{"label":"Share-based Payment Arrangement, Noncash Expense","description":"Amount of noncash expense for share-based payment arrangement.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":92000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":471000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate","description":"The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.","units":{"pure":[{"start":"2020-01-01","end":"2020-03-31","val":0,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":0,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate","description":"The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.","units":{"pure":[{"start":"2020-01-01","end":"2020-03-31","val":0.716,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":0.712,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate","description":"The risk-free interest rate assumption that is used in valuing an option on its own shares.","units":{"pure":[{"start":"2020-01-01","end":"2020-03-31","val":0.0144,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":0.0066,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number","description":"The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.","units":{"shares":[{"end":"2021-03-31","val":2772210,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price","description":"The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.","units":{"USD/shares":[{"end":"2021-03-31","val":4.4,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value","description":"Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.","units":{"USD":[{"start":"2021-01-01","end":"2021-03-31","val":418000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross","description":"Gross number of share options (or share units) granted during the period.","units":{"shares":[{"start":"2021-01-01","end":"2021-03-31","val":2273285,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value","description":"The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.","units":{"USD/shares":[{"start":"2020-01-01","end":"2020-03-31","val":2.4,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":3.15,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value","description":"Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.","units":{"USD":[{"end":"2021-03-31","val":6086000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number","description":"Number of options outstanding, including both vested and non-vested options.","units":{"shares":[{"end":"2020-12-31","val":935478,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q4I"},{"end":"2021-03-31","val":3113640,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price","description":"Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.","units":{"USD/shares":[{"end":"2020-12-31","val":2.56,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q4I"},{"end":"2021-03-31","val":4.41,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1I"}]}},"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice":{"label":"Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price","description":"Weighted average price at which option holders acquired shares when converting their stock options into shares.","units":{"USD/shares":[{"start":"2021-01-01","end":"2021-03-31","val":1.97,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1"}]}},"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice":{"label":"Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price","description":"Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.","units":{"USD/shares":[{"start":"2021-01-01","end":"2021-03-31","val":5.06,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1"}]}},"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value","description":"Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.","units":{"USD":[{"end":"2021-03-31","val":5441000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1I"}]}},"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares","description":"Number of options vested.","units":{"shares":[{"start":"2021-01-01","end":"2021-03-31","val":615517,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1"}]}},"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value","description":"Weighted average grant-date fair value of options vested.","units":{"USD/shares":[{"start":"2021-01-01","end":"2021-03-31","val":2.49,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1"}]}},"SharePrice":{"label":"Share Price","description":"Price of a single share of a number of saleable stocks of a company.","units":{"USD/shares":[{"end":"2021-03-31","val":6.36,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1I"}]}},"StockholdersEquity":{"label":"Stockholders' Equity Attributable to Parent","description":"Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.","units":{"USD":[{"end":"2019-12-31","val":-23127000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2019Q4I"},{"end":"2020-03-31","val":-27434000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q1I"},{"end":"2020-12-31","val":-42115000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q4I"},{"end":"2021-03-31","val":-48717000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1I"}]}},"StockholdersEquityNoteStockSplitConversionRatio1":{"label":"Stockholders' Equity Note, Stock Split, Conversion Ratio","description":"Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.","units":{"pure":[{"end":"2021-04-05","val":0.2235,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1I"}]}},"StockIssuedDuringPeriodSharesStockOptionsExercised":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period","description":"Number of share options (or share units) exercised during the current period.","units":{"shares":[{"start":"2021-01-01","end":"2021-03-31","val":95123,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1"}]}},"StockIssuedDuringPeriodValueStockOptionsExercised":{"label":"Stock Issued During Period, Value, Stock Options Exercised","description":"Value of stock issued as a result of the exercise of stock options.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":26000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":139000,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1"}]}},"WeightedAverageNumberOfShareOutstandingBasicAndDiluted":{"label":"Weighted Average Number of Shares Outstanding, Basic and Diluted","description":"Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).","units":{"shares":[{"start":"2020-01-01","end":"2020-03-31","val":2015029,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":2070935,"accn":"0001558370-21-007568","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-20","frame":"CY2021Q1"}]}}}}}